Linkedin Facebook Twitter Youtube

23 Feb Cytiva

Posted at 19:01h in by

Jenny Pchelinski, Business Development Manager, Cell Lines

Oct. 6 | 9:45am | FLW Ballroom F

Marlborough, MA

(NYSE: DHR)

Genomic medicine, particularly cell and gene therapies, is revolutionizing healthcare. However, challenges in manufacturing and development timelines could hinder widespread adoption. Innovative manufacturing solutions are crucial to address these challenges. Optimizing process will not be enough, advanced technologies are needed to get to the next level. Cytiva is dedicated to accelerating the development and production of these life-saving therapies through innovative technology. Our expertise in advanced therapies, including viral vectors, cell therapies, and RNA-based therapies, enables us to support the entire development journey, from early-stage research to commercial manufacturing.

www.cytivalifesciences.com



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,500 attendees – over 30% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 5-7, 2026
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions